QQQ $ 602.61 $ 4.22 (0.71 %)
DIA $ 463.04 $ 0.00 (0 %)
SPY $ 665.11 $ 2.94 (0.44 %)
TLT $ 90.76 $ -0.20 (-0.22 %)
GLD $ 387.41 $ 6.60 (1.73 %)
$ 1.0E-6
-- x --
-- x --
-- - --
$ 0.00 - $ 5.24
48
na
na
$ 1.04
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

https://www.marijuanamoment.net/rfk-says-trump-administration-could-provide-psychedelic-therapy-to-military-veterans-within-12-...

Core News & Articles

https://www.statnews.com/2025/06/18/fda-approval-psychedelics-rfk-jr-trump-allies-see-opening-mdma-psilocybin-mental-health-tre...

Core News & Articles

https://subscriber.politicopro.com/article/2025/05/va-secretary-wants-to-find-answers-on-psychedelic-therapies-for-veterans-003...

 seelos-therapeutics-delisted-from-nasdaq-will-transition-to-otc-market

Seelos Therapeutics announces delisting from Nasdaq due to failure to meet equity requirements, with trading set to shift to OT...

 seelos-therapeutics-announces-1-for-16-reverse-stock-split-will-begin-trading-on-a-reverse-stock-split-adjusted-basis-at-the-opening-of-the-market-on-friday-september-27-2024

Seelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical compan...

 whats-going-on-with-seelos-therapeutics-stock-tuesday

Seelos shares are trading higher Tuesday after the company announced that it signed a material transfer agreement to supply SLS...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION